|
RNPC3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.01220000048308E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.06910000039629E-07 |
| Normal-vs-Stage2 |
1.180660E-03 |
| Normal-vs-Stage3 |
8.344300E-03 |
| Normal-vs-Stage4 |
1.024580E-01 |
| Stage1-vs-Stage2 |
3.026400E-01 |
| Stage1-vs-Stage3 |
3.732600E-01 |
| Stage1-vs-Stage4 |
1.833230E-01 |
| Stage2-vs-Stage3 |
1.396180E-01 |
| Stage2-vs-Stage4 |
8.527700E-02 |
| Stage3-vs-Stage4 |
6.298800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.949300000476E-07 |
| Normal-vs-AfricanAmerican |
9.260900E-03 |
| Normal-vs-Asian |
5.142100E-02 |
| Caucasian-vs-AfricanAmerican |
4.429400E-01 |
| Caucasian-vs-Asian |
3.844400E-01 |
| AfricanAmerican-vs-Asian |
6.366600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.814500E-04 |
| Normal-vs-Female |
1.50960000055989E-08 |
| Male-vs-Female |
2.682200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.579200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.28849999994729E-06 |
| Normal-vs-Age(61-80Yrs) |
1.212220E-04 |
| Normal-vs-Age(81-100Yrs) |
8.400100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.709600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.019400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.116000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.642000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.629200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.319200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.435800E-02 |
| Normal-vs-Grade 2 |
1.40810000326397E-08 |
| Normal-vs-Grade 3 |
1.821910E-03 |
| Normal-vs-Grade 4 |
7.530200E-01 |
| Grade 1-vs-Grade 2 |
1.562570E-01 |
| Grade 1-vs-Grade 3 |
7.453500E-02 |
| Grade 1-vs-Grade 4 |
2.883800E-02 |
| Grade 2-vs-Grade 3 |
4.439500E-02 |
| Grade 2-vs-Grade 4 |
2.217600E-04 |
| Grade 3-vs-Grade 4 |
4.648300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.35189986877538E-10 |
| Normal-vs-ccB subtype |
7.911900E-02 |
| ccA subtype-vs-ccB subtype |
3.68640000000253E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.14640000004052E-06 |
| Normal-vs-N1 |
6.004400E-01 |
| N0-vs-N1 |
6.059100E-03 |
|
|
